Hormone Therapy and Risk of Dementia – What the Evidence Tells Us So Far

Learn the latest about the association between hormone therapy use and dementia risk.

Participants are expected to watch the video, reflect on its content, and complete the CEU self-assessment and CEU evaluation. Only upon completing this process will a participant's continuing education certificate be generated. The estimated time a learner will need to complete this self-study activity is 30 minutes. 

This activity is approved for continuing education for physicians, nurses, and dietitians.

The George Washington University School of Medicine and Health Sciences designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives:

• To present the existing evidence on the potential causal link between use of menopausal hormone therapy and increased risk of dementia.
• To compare findings and the quality of evidence across study types (randomized controlled trials versus observational studies), hormones (conjugated estrogens versus estradiol; progestins versus progesterone), and different durations and dosages of hormone therapy use.
• To present the latest findings from a nationwide study on the dementia risk with hormone therapy use with a focus on the potential dementia link with short-term use around the age of menopause, which is the currently recommended regimen of use.

Requirements for successful completion: Participants will be awarded contact hours commensurate with participation after completion of the post-test with a score of 70% or higher.